MMC
Sponsors
University of Colorado, Denver, Shiyou Zhou, Sun Yat-sen University, Shahid Beheshti University of Medical Sciences, Janssen Research & Development, LLC
Conditions
Bladder CancerGlaucomaNon-Muscle Invasive Bladder NeoplasmsPterygiumRecurrent Pterygium
Phase 1
Phase 3
Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method
NCT02385370
Start: 2014-12-31Target: 126Updated: 2015-03-11
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
RecruitingNCT06319820
Start: 2024-04-18End: 2032-12-31Target: 641Updated: 2026-09-25
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) and Pembrolizumab (MK-3475A) in Participants With Bladder Cancer (MK-2870-055)
Not yet recruitingNCT07829783
Start: 2026-10-20End: 2036-09-25Target: 400Updated: 2026-09-21
Unknown Phase
Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane
CompletedNCT01319721
Start: 2010-12-31End: 2014-06-30Updated: 2015-03-19
Intraoperative Mitomycin C, Amniotic Membrane Transplantation and Conjunctival Autograft for Primary Pterygium
NCT02102776
Start: 2015-12-31End: 2017-12-31Target: 750Updated: 2015-12-17